Korelasi kadar high-sensitivity C-reactive protein dengan gangguan kognitif pada pasien stroke iskemia akut

https://doi.org/10.22146/bns.v19i1.61892

Fajar Prabowo(1*), Sri Sutarni(2), Astuti Astuti(3)

(1) Universitas Gadjah Mada, Yogyakarta
(2) Departemen Neurologi, Fakultas Kedokteran-Kesehatan Masyarakat dan Keperawatan Universitas Gadjah Mada, Yogyakarta
(3) Departemen Neurologi, Fakultas Kedokteran-Kesehatan Masyarakat dan Keperawatan Universitas Gadjah Mada, Yogyakarta
(*) Corresponding Author

Abstract


The incidence of acute cognitive impairment in stroke patients occurred in about 80% of patients and 38-73% of them became impaired permanently. Increased of inflammatory markers as a response to stroke inflamation are associated with poor outcomes in stroke patients. HsCRP level is one of the vascular cognitive impairment predictor in ischemic stroke patients.

This study aims to determine the correlation of hsCRP levels in determining the occurrence of cognitive function disorder in patients with acute ischemic stroke at RSUP Sardjito Yogyakarta. The design was prospective cohort observational study with the subject of the first acute ischemic stroke patients. Cognitive impairment was assessed using the Montreal Cognitive Assessment versi Indonesia (MoCA-Ina) score at discharge. The hsCRP level was examined at <72h onset. All data was processed with computerized statistical analysis.

A total of 30 subjects followed the study with mean age 61.93±11.916 years and hsCRP levels of 3.35±2.23 g/dL. The result of bivariate analysis showed that one factor significantly influence cognitive impairment of ischemic stroke patients, that is hsCRP levels (r =-0.538, p =0.002). Multivariate analysis showed that hsCRP levels (β =-0.5, p =0.003) were independent factors affecting cognitive impairment of acute ischemic stroke.

Based on this study, there is a correlation between hsCRP levels with acute ischemic stroke cognitive impairment, that is, the higher hsCRP levels, the lower MoCA-Ina values.

 

ABSTRAK

 

Kejadian gangguan kognitif secara akut pada penderita stroke terjadi pada sekitar 80% pasien dan 38-73% di antaranya menjadi menetap. Peningkatan penanda inflamasi sebagai respons inflamasi stroke berhubungan terhadap luaran yang buruk pada pasien stroke. Kadar hsCRP merupakan salah satu yang dapat dijadikan prediktor gangguan kognitif vaskular pada pasien stroke infark.

Penelitian ini bertujuan untuk mengetahui korelasi kadar hsCRP dalam menentukan terjadinya gangguan fungsi kognitif pada pasien stroke iskemia akut di RSUP Dr. Sardjito Yogyakarta. Rancangan penelitian ini adalah observasional kohort prospektif dengan subjek pasien serangan stroke iskemia akut pertama. Gangguan kognitif dinilai menggunakan skor Montreal Cognitive Assessment versi Indonesia (MoCA-Ina). Kadar hsCRP diperiksa pada <72 jam sejak serangan stroke. Seluruh data kemudian diolah untuk analisis statistik secara komputerisasi.

Sebanyak 30 subjek mengikuti penelitian dengan rerata usia 61,93±11,916 tahun dan kadar hsCRP 3,35±2,23 g/dL. Pada hasil analisis bivariat didapatkan 1 faktor bermakna secara signifikan memengaruhi gangguan kognitif pasien stroke iskemia yaitu kadar hsCRP (r =-0,538, p =0,002). Setelah dilakukan analisis multivariat didapatkan bahwa kadar hsCRP (β =-0,5, p =0,003) merupakan faktor independen yang mempengaruhi gangguan kognitif stroke iskemia akut.

Berdasarkan penelitian ini, terdapat korelasi kadar hsCRP dengan ganguan kognitif stroke iskemia akut yaitu makin tinggi kadar hsCRP, makin rendah nilai MoCA-Ina


Keywords


hsCRP;MoCA-Ina;cognitive impairment;ischemic stroke



References

Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133(4):447-454.

Yudiarto F, Machfoed M, Darwin A, Ong A, Karyana M, Siswanto. Indonesia Stroke Registry. Neurology. 2014;82(10 Supplement):S12.003.

Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bulletin of the World Health Organization. 1980;58(1):113-130.

Rathore SS, Hinn AR, Cooper LS, Tyroler HA, Rosamond WD. Characterization of incident stroke signs and symptoms: findings from the atherosclerosis risk in communities study. Stroke. 2002;33(11):2718-2721.

Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon III RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499–511.

Vila N, Castillo J, Davalos A, Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Journal of Cerebral Circulation. 2000;31(10):2325–2329.

Whiteley W, Jackson C, Lewis S, Lowe G, Rumley A, Sandercock P, et al. Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS medicine. 2009;6(9):e1000145.

Lesniak M, Bak T, Czepiel W, Seniow J, Członkowska A. Frequency and prognostic value of cognitive disorders in stroke patients. Dementia and Geriatric Cognitive Disorders. 2008;26(4):356–363.

An XL, Li CL. Analysis of risk factors for vascular cognitive impairment in patients with cerebral infarction. Cell Biochemistry and Biophysics. 2015;71(2):673-677.

Noble JM, Manly JJ, Schupf N, Tang MX, Mayeux R, Luchsinger JA. Association of C-reactive protein with cognitive impairment. Archives of Neurology. 2010;67(1):87-92.

Tan ZS, Beiser AS, Vasan RS, Roubenoff R, Dinarello CA, Harris TB, et al. Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology. 2007;68(22):1902-1908.

Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA. 2004;292(18):2237-2242.

Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, et al. Inflammatory proteins in plasma and the risk of dementia: The Rotterdam Study. Archives of Neurology. 2004;61(5):668-672.

Wersching H, Duning T, Lohmann H, Mohammadi S, Stehling C, Fobker M, et al. Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function. Neurology. 2010;74(13):1022–1029.

Komulainen P, Lakka TA, Kivipelto M, Hassinen M, Penttilä IM, Helkala EL, et al. Serum high sensitivity C-reactive protein and cognitive function in elderly women. Age and Ageing. 2007;36(4):443-448.

Alexandrova ML, Danovska MP. Cognitive impairment one year after ischemic stroke: predictors and dynamics of significant determinants. Turkish journal of Medical Sciences. 2016;46(5):1366-1373.

Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ. Early inflammation and dementia: a 25‐year follow‐up of the Honolulu‐Asia Aging Study. Annals of Neurology. 2002;52(2):168-174.

Gorelick PB, Scuteri A, Black SE, DeCarli C, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(9):2672–2713.

Murman DL. The impact of age on cognition. In: Seminars in hearing. Thieme Medical Publishers; 2015.



DOI: https://doi.org/10.22146/bns.v19i1.61892

Article Metrics

Abstract views : 519 | views : 972

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Berkala NeuroSains

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.